Search

Kindred Companion Sciences will face regulatory and ethics scrutiny before any commercial rollout of Can f 1–knockout dogs.

If replicated and scaled, targeted pet gene editing could create a new consumer biotech category—while reigniting ethical and regulatory debates around engineered companion animals.

Cities will face louder demands to audit Flock systems after more wrongful stops and privacy protests.

This is a classic adoption-versus-accountability story. The technology is spreading, but the public conversation is shifting from crime-solving utility to error rates, civil liberties and police verification failures.